WallStreetZenWallStreetZen

NASDAQ: PMCB
Pharmacyte Biotech Inc Stock Ownership - Who owns Pharmacyte Biotech?

Insider buying vs selling

Have Pharmacyte Biotech Inc insiders been buying or selling?
No trades
There has been no insiders buying vs selling in the past 12 months.

Be the first to know when PMCB insiders and whales buy or sell their stock.

PMCB Shareholders

What type of owners hold Pharmacyte Biotech Inc stock?
Institutional
Insider
Retail
NameHoldSharesValueType
Daniel Stuart Farb8.44%714,570$1.39MInsider
K2 Principal Fund LP3.87%327,503$638.63kInstitution
Daniel Allen3.07%260,000$507.00kInsider
Geode Capital Management LLC2.37%200,281$390.55kInstitution
Vanguard Group Inc2.06%174,602$340.47kInstitution
Equitec Proprietary Markets LLC0.98%82,727$161.32kInstitution
Jonathan Schechter0.59%50,000$97.50kInsider
Joshua Silverman0.59%50,000$97.50kInsider
Renaissance Technologies LLC0.52%43,800$85.41kInstitution
Susquehanna International Group LLP0.49%41,188$80.32kInstitution

1 of 3

PMCB vs Biotech Stocks

TickerInst. %Insider %Net Insider (L12M)Net Insider (L3M)
PMCB11.55%13.29%
SNSE9.21%71.96%Net Selling
LYRA74.73%14.19%Net Buying
GLYC36.64%63.36%Net BuyingNet Buying
NRXS1.12%39.67%Net Buying

Pharmacyte Biotech Stock Ownership FAQ

Who owns Pharmacyte Biotech?

Pharmacyte Biotech (NASDAQ: PMCB) is owned by 11.55% institutional shareholders, 13.29% Pharmacyte Biotech insiders, and 75.15% retail investors. Daniel Stuart Farb is the largest individual Pharmacyte Biotech shareholder, owning 714,570.00 shares representing 8.44% of the company. Daniel Stuart Farb's Pharmacyte Biotech shares are currently valued at $1.39M.

If you're new to stock investing, here's how to buy Pharmacyte Biotech stock.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.